...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Question on valuing shares from time of spinoff

,,,,,If it is equated back to RVX via the market price, when the spin out took place, then it was about a buck CAD,,,,as RVX dropped that much the following trading session,,,,, they show up in both my accounts at .623 cents,,,,,,,!

Share
New Message
Please login to post a reply